Search

everythinglearnresearchcommunity

for

Search:↓

Different hair and nail conditions can indicate health issues and have specific treatments; accurate diagnosis is crucial before treatment.

Up to half of adult women may experience hair loss, and doctors should use medical history, exams, and tests to find the cause and treat it.

Melatonin may help reduce the needed dose of prednisolone and improve hair growth in alopecia areata patients.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Stress hormones and autoimmune reactions can cause hair loss.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

People with alopecia areata are more likely to have other immune-related conditions.

Thyroid hormones are important for skin health and changes in them can affect conditions like hair loss and eczema.

GLPLS and LPP are variants of lichen planus.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

A rabbit with sebaceous adenitis was effectively treated with ciclosporin and medium-chain triglycerides.

Atopic dermatitis increases the risk of some autoimmune diseases.

People with alopecia areata may be more likely to have a certain type of hearing loss.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

The girl's regrown brown hair had less of certain pigments than her original black hair.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.